Read the original Providence Business News article By PBN Staff PROVIDENCE – Prominent local researcher and University of Rhode Island professor Dr. Anne S. De Groot has been awarded a $13 million research grant from the National Institutes of Health. It is the second large NIH grant awarded to URI researchers in recent months. In May, a pharmacy ...

Read the original article in the Providence Journal By C. Eugene Emery Jr. PROVIDENCE — Dr. Annie De Groot and her colleagues think they have a better way of speeding the development of vaccines against Lyme disease, hepatitis and stomach cancer. The federal government apparently believes their ideas are worth a ...

Simulation tools used to train next generation of scientific researchers PROVIDENCE, R.I. – July 28, 2009 University of Rhode Island Professor Annie De Groot has been awarded a $13 million grant from the National Institutes of Health to pioneer the development and application of an integrated gene-to-vaccine program targeting emerging infectious diseases.  It is the second multi-million ...

EpiVax is proud to be presenting our research findings at numerous conferences in the coming months, including: Strategies for Engineered Negligible Senescence (SENS4) 3rd Annual Therapeutic Monoclonal Antibody Discovery Immunogenicity Testing: Clinical and Regulatory Strategy for Biopharmaceuticals Immunogenicity Summit Three oral and two poster presentations at 2nd European Congress of Immunology  

Vaccine research has helped her make a difference By Marion Davis Contributing Writer SEARCHING FOR A CURE: Anne De Groot founded EpiVax in 1998 with her research partner Bill Martin. The company has developed vaccines for HIV, tuberculosis, smallpox and other diseases. PBN PHOTO/STEPHANIE EWENS Dr. Anne S. De Groot went to medical school, she said, “to right the wrongs ...

PBN honors Business Women winners By PBN Staff PROVIDENCE – Providence Business News today held a luncheon to recognize the accomplishments of the 26 women honored over the past year as part of the newspaper’s second annual program recognizing women in the Rhode Island business community. The luncheon this afternoon at the Providence Marriott Downtown on Orms Street ...

Amazing Women Degroot Dr. Anne De Groot and Amazing Women host Deb Ruggiero talk about immunology, immunoinformatics, and diabetes research. The program is split into two segments, each 11 minutes long. (Player requires Flash and JavaScript)

Amazing Women Degroot Dr. Anne De Groot and Amazing Women host Deb Ruggiero talk about immunology, immunoinformatics, and diabetes research. The program is split into two segments, each 11 minutes long. (Player requires Flash and JavaScript)

In early May, Dr. Annie De Groot will be presenting to the NIH/NIAID regarding next generation epitope-driven vaccines: "More Effector Epitopes, Less Heterologous Epitopes, and no T-regitopes?" The presentation will be hosted by David Sacks, PhD, Chief of Intracellular Parasite Biology Section for the National Institute on Allergy and Infectious Diseases.   While whole killed, whole protein, ...

The Providence Business News has chosen Dr. Annie De Groot as this year's receipient of the Overall Career Achievement Award. From the nomination: Dr. De Groot has a vision for Rhode Island; she sees our state as being the leader in biotechnology, an engine in the new knowledge economy, and a model for economic redevelopment to the ...

http://www.projo.com/business/content/BZ_FATHER_DAUGHTER_02-24-09_H5DCTR0_v45.3093601.html PROVIDENCE – The equipment and building are new, but there is something familiar about Annie De Groot’s new digs: her father, who was among her first faculty appointments at the University of Rhode Island. When Annie De Groot, a Brown University professor and the chief executive officer of EpiVax, was given the job of directing ...

http://www.projo.com/business/content/BZ_INFORMATICS_02-24-09_H5DCOE1_v111.308ebf3.html PROVIDENCE –– The University of Rhode Island has hired the founder of one of the state’s best-known biotechnology firms to lead researchers in thedevelopment of vaccines against malaria, AIDS and tuberculosis. Annie S. De Groot, 53, is not leaving EpiVax Inc., the Providence-based company she helped create in 1998, building on software technology she developed ...

http://www.masshightech.com/stories/2009/02/09/daily43-URI-taps-De-Groot-to-head-new-vaccine-research-center.html The University of Rhode Island’s (URI) biotechnology center in Providence is creating an institute to research the prevention and cure of so-called neglected animal and human diseases, which will be led by Annie De Groot, the CEO of biotech EpiVax Inc. The purpose of the new program, called the Institute for Immunology and Informatics, is to ...

EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery December 1, 2008 (Providence, RI)–EpiVax, Inc, a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to optimize delivery of ...

EpiVax was profiled in an article for Xconomy, which lists five "firms to watch" in Rhode Island who have utilized innovative strategies to grow their companies despite an period of economic downturn that has affected both the state and the country. Specifically, the article states that: "EpiVax uses an informatics system developed by founder and CEO Annie De ...